Leukemia is relatively uncommon compared to other major cancers but far from rare in absolute numbers. About 67,000 to 68,000 Americans are diagnosed each year, with an incidence rate of 14.7 per 100,000 people. That makes it the tenth most common cancer in the United States, well behind breast cancer (319,750 annual cases), prostate cancer (313,780), and lung cancer (226,650).
How Leukemia Compares to Other Cancers
To put leukemia in context, the American Cancer Society projects roughly 2 million new cancer cases across all types in 2025. Leukemia accounts for about 3.3% of that total. It ranks behind breast, prostate, lung, colorectal, melanoma, non-Hodgkin lymphoma, bladder, kidney, and pancreatic cancers in terms of new diagnoses. So while tens of thousands of people receive a leukemia diagnosis every year, your odds of developing it are significantly lower than for the cancers you hear about most often.
An incidence rate of 14.7 per 100,000 means that in a city of 100,000 people, roughly 15 would be diagnosed in a given year. For comparison, breast cancer strikes about 130 per 100,000 women annually, and lung cancer affects around 50 per 100,000 people overall.
Who Gets Leukemia Most Often
Leukemia isn’t a single disease. It’s a group of blood cancers, and each type strikes different age groups at very different rates. The four main subtypes are acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Acute forms develop quickly and require immediate treatment, while chronic forms progress more slowly.
ALL is the most common leukemia in children. Childhood leukemia overall represents 25.7% of all pediatric cancers, making it the single most common cancer in kids, with a rate of 4.9 per 100,000 children per year. Despite this, childhood leukemia is still uncommon in absolute terms. Most parents will never encounter it.
In adults, the picture flips. CLL and AML become far more common with age, and the overall risk of leukemia climbs steeply after 55. The majority of leukemia diagnoses occur in older adults. AML in particular is heavily concentrated in people over 65.
Breakdown by Leukemia Type
Among all leukemia cases, the subtypes are not equally common:
- ALL (acute lymphocytic leukemia) makes up the largest share in populations that include children, accounting for a substantial portion of diagnoses. It’s the most common childhood cancer but also occurs in adults.
- AML (acute myeloid leukemia) represents roughly 24% of cases and is the most common acute leukemia in adults. It is also the most aggressive, with a five-year survival rate of about 33%.
- CML (chronic myeloid leukemia) accounts for roughly 10% of cases. It was once considered very serious but is now highly manageable with targeted therapy for most patients.
- CLL (chronic lymphocytic leukemia) is the most common leukemia in adults in the U.S. and Western countries. It tends to grow slowly, and many people live with it for years, sometimes without needing treatment right away.
These proportions shift depending on the population studied. In the U.S. adult population specifically, CLL is the most frequently diagnosed subtype, while in younger populations ALL dominates.
Survival Rates Vary Widely by Type
How serious a leukemia diagnosis is depends enormously on which type you’re talking about. Childhood ALL has one of the best outcomes of any cancer, with cure rates exceeding 90% in many treatment centers. AML, on the other hand, carries a five-year relative survival rate of roughly 33%, meaning about one in three patients is alive five years after diagnosis. That number is even lower for older adults diagnosed with AML.
CLL and CML generally have much better outlooks. CML survival improved dramatically after targeted therapies became available in the early 2000s, and many patients now have near-normal life expectancies. CLL often progresses so slowly that some patients are monitored for years before treatment becomes necessary, a strategy called “watchful waiting.”
Risk in Everyday Terms
At the individual level, your chance of being diagnosed with any form of leukemia in a given year is very small. With roughly 68,000 new cases among 330 million Americans, that works out to about 1 in 5,000 people per year. Over a full lifetime the cumulative risk is higher, but leukemia remains one of the less common cancers you might face.
Certain factors nudge that risk upward. Exposure to high levels of radiation, long-term exposure to certain industrial chemicals like benzene, previous chemotherapy or radiation treatment for another cancer, smoking, and some genetic conditions all increase the likelihood. Men are diagnosed slightly more often than women across most subtypes. But for most people, none of these risk factors apply, and the baseline risk stays low.
If you’re comparing leukemia to truly rare cancers, it’s worth noting that cancers like gallbladder cancer, mesothelioma, or cancers of the small intestine each affect only a few thousand Americans per year. At nearly 68,000 annual diagnoses, leukemia is uncommon but not in the same category as those genuinely rare diseases. It falls in a middle zone: not one of the big five cancers that dominate headlines, but common enough that most oncology centers see it regularly and have well-established treatment pathways.